29 results on '"Peyronnet V"'
Search Results
2. Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire
- Author
-
Huré, M., Peyronnet, V., Sibiude, J., Cazenave, M.G., Anselem, O., Luton, D., Vauloup-Fellous, C., Deruelle, P., Cordier, A.G., Benachi, A., Mandelbrot, L., Couffignal, C., Pauphilet, V., Vivanti, A.J., and Picone, O.
- Published
- 2022
- Full Text
- View/download PDF
3. Infection par le SARS-CoV-2 chez les femmes enceintes. Actualisation de l’état des connaissances et de la proposition de prise en charge. CNGOF
- Author
-
Peyronnet, V., Sibiude, J., Huissoud, C., Lescure, F.-X., Lucet, J.-C., Mandelbrot, L., Nisand, I., Belaish-Allart, J., Vayssière, C., Yazpandanah, Y., Luton, D., and Picone, O.
- Published
- 2020
- Full Text
- View/download PDF
4. Smoking and smoking cessation in pregnancy. Synthesis of a systematic review
- Author
-
Grangé, G., Berlin, I., Bretelle, F., Bertholdt, C., Berveiller, P., Blanc, J., DiGuisto, C., Dochez, V., Garabedian, C., Guerby, P., Koch, A., Le Lous, M., Perdriolle-Galet, E., Peyronnet, V., Rault, E., Torchin, H., and Legendre, G.
- Published
- 2020
- Full Text
- View/download PDF
5. Prise en charge non pharmacologique du sevrage tabagique pendant la grossesse – Rapport d’experts et recommandations CNGOF-SFT sur la prise en charge du tabagisme en cours de grossesse
- Author
-
Peyronnet, V., Koch, A., Rault, E., Perdriolle-Galet, E., and Bertholdt, C.
- Published
- 2020
- Full Text
- View/download PDF
6. Rapport d’experts et recommandations CNGOF-SFT sur la prise en charge du tabagisme en cours de grossesse—texte court
- Author
-
Grangé, G., Berlin, I., Bretelle, F., Bertholdt, C., Berveiller, P., Blanc, J., DiGuisto, C., Dochez, V., Garabedian, C., Guerby, P., Koch, A., Le Lous, M., Perdriolle-Galet, E., Peyronnet, V., Rault, E., Torchin, H., and Legendre, G.
- Published
- 2020
- Full Text
- View/download PDF
7. Post-partum chez la femme tabagique sevrée en cours de grossesse : gestion du risque de reprise — Rapport d’experts et recommandations CNGOF-SFT sur la prise en charge du tabagisme en cours de grossesse
- Author
-
Perdriolle-Galet, E., Peyronnet, V., and Bertholdt, C.
- Published
- 2020
- Full Text
- View/download PDF
8. Infection par le SARS-CoV-2 chez les femmes enceintes : état des connaissances et proposition de prise en charge par CNGOF
- Author
-
Peyronnet, V., Sibiude, J., Deruelle, P., Huissoud, C., Lescure, X., Lucet, J.-C., Mandelbrot, L., Nisand, I., Vayssière, C., Yazpandanah, Y., Luton, D., and Picone, O.
- Published
- 2020
- Full Text
- View/download PDF
9. Impact of Recommended Changes in Labor Management for Prevention of the Primary Cesarean Delivery
- Author
-
Thuillier, C., Roy, S., Peyronnet, V., Quibel, T., Nlandu, A., and Rozenberg, P.
- Published
- 2018
- Full Text
- View/download PDF
10. Impact de la détection anténatale d’un fœtus petit pour l’âge gestationnel sur le pronostic néonatal
- Author
-
Peyronnet, V., primary, Sibiude, J., additional, Mandelbrot, L., additional, and Kayem, G., additional
- Published
- 2018
- Full Text
- View/download PDF
11. Détection des fœtus petits pour l’âge gestationnel lors de l’échographie du troisième trimestre. Étude observationnelle monocentrique
- Author
-
Peyronnet, V., primary, Kayem, G., additional, Mandelbrot, L., additional, and Sibiude, J., additional
- Published
- 2016
- Full Text
- View/download PDF
12. [How I do … interpret CMV serology during pregnancy?]
- Author
-
Vauloup-Fellous C, Peyronnet V, Portet-Sulla V, and Picone O
- Subjects
- Humans, Female, Pregnancy, Cytomegalovirus immunology, Cytomegalovirus isolation & purification, Antibodies, Viral blood, Serologic Tests methods, Cytomegalovirus Infections diagnosis, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious virology
- Published
- 2024
- Full Text
- View/download PDF
13. Perinatal outcomes between immediate vs deferred selective termination in dichorionic twin pregnancies with fetal congenital anomalies: a French multicenter study.
- Author
-
Soussan S, Egloff C, Peyronnet V, Winer N, Weingertner AS, Rault E, Fuchs F, Quibel T, Bourgon N, Vivanti AJ, Rosenblatt J, Ponzio-Klijanienko A, Dap M, Mandelbrot L, and Picone O
- Subjects
- Humans, Pregnancy, Female, Retrospective Studies, France epidemiology, Adult, Infant, Newborn, Premature Birth prevention & control, Premature Birth epidemiology, Pregnancy Outcome epidemiology, Pregnancy Trimester, Third, Gestational Age, Pregnancy Reduction, Multifetal methods, Pregnancy Reduction, Multifetal statistics & numerical data, Time Factors, Abortion, Spontaneous epidemiology, Abortion, Spontaneous prevention & control, Pregnancy, Twin, Congenital Abnormalities diagnosis, Congenital Abnormalities epidemiology, Congenital Abnormalities prevention & control
- Abstract
Background: Because selective termination for discordant dichorionic twin anomalies carries a risk of pregnancy loss, deferring the procedure until the third trimester can be considered in settings where it is legal., Objective: To determine whether perinatal outcomes were more favorable following deferred rather than immediate selective termination., Study Design: A French multicenter retrospective study from 2012 to 2023 on dichorionic twin pregnancies with selective termination for fetal conditions, which were diagnosed before 24 weeks gestation. Pregnancies with additional risk factors for late miscarriage were excluded. We defined 2 groups according to the intention to perform selective termination within 2 weeks after the diagnosis of the severe fetal anomaly was established (immediate selective termination) or to wait until the third trimester (deferred selective termination). The primary outcome was perinatal survival at 28 days of life. Secondary outcomes were pregnancy losses before 24 weeks gestation and preterm delivery., Results: Of 390 pregnancies, 258 were in the immediate selective termination group and 132 in the deferred selective termination group. Baseline characteristics were similar in both groups. Overall survival of the healthy co-twin was 93.8% (242/258) in the immediate selective termination group vs 100% (132/132) in the deferred selective termination group (P<.01). Preterm birth <37 weeks gestation was lower in the immediate than in the deferred selective termination group (66.7% vs 20.2%; P<.01); preterm birth <28 weeks gestation and <32 weeks gestation did not differ significantly (respectively 1.7% vs 0.8%; P=.66 and 8.26% vs 11.4%; P=.36). In the deferred selective termination group, an emergency procedure was performed in 11.3% (15/132) because of threatened preterm labor, of which 3.7% (5/132) for imminent delivery., Conclusion: Overall survival after selective termination was high regardless of the gestational age at which the procedure was performed. Postponing selective termination until the third trimester seems to improve survival, whereas immediate selective termination reduces the risk of preterm delivery. Furthermore, deferred selective termination requires an expert center capable of performing the selective termination procedure on an emergency basis if required., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Comparison of pregnancy outcomes after bariatric surgery by sleeve gastrectomy versus gastric bypass.
- Author
-
Joly MA, Peyronnet V, Coupaye M, Ledoux S, Pourtier N, Pencole L, and Mandelbrot L
- Abstract
Objective: Bariatric surgery has an impact on subsequent pregnancies, in particular an association between gastric bypass and small for gestational age. Knowledge is lacking on whether sleeve gastrectomy is associated with more favorable pregnancy outcomes. This study aimed to compare the impact of sleeve gastrectomy and Roux-en-Y gastric bypass on the incidence of small for gestational age (SGA), and of adverse pregnancy outcomes., Study Design: We conducted a retrospective study in a single reference center, including all patients with a history of sleeve or bypass who delivered between 2004 and 2021 after their first pregnancy following bariatric surgery. We compared the incidence of SGA, intrauterine growth retardation, preterm delivery and adverse maternal outcomes between patients who had sleeve versus bypass., Results: Of 244 patients, 145 had a sleeve and 99 had a bypass. The proportion of SGA < 10th percentile did not differ between the two groups (38/145 (26.2 %) vs 22/99 (22.22 %), respectively, p = 0.48). Preterm birth < 37 WG was lower in the sleeve group (5/145 (3.45%) vs 12/99 (12.12 %) in the bypass group (p = 0.01), as well as NICU hospitalizations (3 (2.07%) vs 12/99 (12.12%), p < 0.01). There was no difference regarding adverse maternal outcomes such as gestational diabetes and hypertensive complications. The proportion of SGA was not lower in patients with bypass when adjusting for other risk factors (BMI, smoking, geographic origin, diabetes and hypertension) (aOR 0.70; 95%CI 0.01 - 2.85)., Conclusion: sleeve was associated with an incidence of SGA which was as high as after bypass, however the incidence of preterm birth was lower., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
15. Induction or spontaneous labor for pregnant patients on anticoagulants?
- Author
-
Mauny L, Peyronnet V, Peynaud-Debayle E, Picone O, Nebout S, and Mandelbrot L
- Subjects
- Pregnancy, Humans, Female, Retrospective Studies, Cesarean Section, Heparin, Low-Molecular-Weight adverse effects, Pain, Anticoagulants adverse effects, Thrombosis
- Abstract
Objective: There are two approaches to peripartum management for pregnant patients undergoing anticoagulation treatments: spontaneous labor or scheduling an induction. A long interval without anticoagulation is a thrombosis risk factor, while a short interval leads to risks of delivery without epidural analgesia or post partum hemorrhage. Our objective was to evaluate the impact of planned induction versus spontaneous labor on obtaining neuraxial analgesia., Materials and Methods: A retrospective single-center study was conducted from 2012 to 2020 including all patients on preventive or curative low molecular-weight heparin at the time of delivery, excluding planned cesarean sections. The rates of neuraxial analgesia were compared between two groups: spontaneous labor and induction, as well as the intervals without anticoagulants., Results: 127 patients were included. In the spontaneous labor group, 78% (44/56) received neuraxial analgesia versus 88% (37/42) in the induction group (p = 0.29). For curative dose treatment, the rate of neuraxial analgesia was 45,5% in the spontaneous group versus 78,6% (p = 0.12). The median time without anticoagulation was 34 h [26-46] in the spontaneous labor group and 43 h [34-54] in the induction group (p = 0.01), without an increased incidence of thrombosis. The rate of postpartum hemorrhage did not differ between the two groups., Conclusion: Planned induction tended to increase the rate of neuraxial analgesia, without reaching significance, and most women in spontaneous labor accessed analgesia. Peripartum management should be a shared decision with the patient considering the obstetrical and thrombosis risk context for each patient., Competing Interests: Declaration of Competing Interest The authors report no conflict of interest, (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
16. Contribution of amniocentesis in fetuses small for gestational age without other sonographic signs.
- Author
-
Labaye S, Peyronnet V, Coussement A, Mandelbrot L, and Picone O
- Subjects
- Pregnancy, Female, Humans, Infant, Newborn, Gestational Age, Retrospective Studies, In Situ Hybridization, Fluorescence, Fetal Growth Retardation, Fetus, Amniocentesis, Infant, Newborn, Diseases
- Abstract
Objective: Our study evaluated the contribution of amniocentesis in the diagnostic approach of small-for-gestational-age fetuses (SGA) without morphological abnormality identified on ultrasound by studying FISH (fluorescence in situ hybridization) for chromosomes 13, 18 and 21, CMV PCR (cytomegalovirus polymerase chain reaction), karyotype and CGH (genomic hybridization array) METHODS: Our single-center retrospective cohort study included pregnant women referred for prenatal diagnosis for a SGA fetus in whom amniocentesis was performed between 2016 and 2019. A SGA fetus was defined as a fetus with an estimated fetal weight (EFW) below the 10th percentile according to referral growth curves in use. We evaluated the number of amniocenteses with an abnormal result and identified factors that may be associated with this outcome., Results: Among the 79 amniocenteses performed, there were 5 (6.3%) abnormalities: karyotype (1.3%) and CGH (5.1%). No complications were described. We did not find any statistically significant factors associated with abnormal amniocentesis findings even if some elements seemed reassuring such as late discovery (p = 0.31), moderate SGA (p = 0.18), normal head, abdomen and femur measurements (p = 0.57), but without statistically significant difference., Conclusion: Our study found 6.3% pathological analysis of amniocenteses, of which several would have been missed by conventional karyotyping. Patients must be informed about the risk of detecting abnormalities of low severity, with low penetrance or with unknown fetal consequences that could be source of anxiety., Competing Interests: Declaration of Competing Interest The authors declare that they have no competing interest., (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
17. Impact of Crohn's disease on obstetrical management.
- Author
-
Payet L, Peyronnet V, Thouny C, Coffin B, Ceccaldi PF, M'Barek IB, Treton X, Letendre I, and Mandelbrot L
- Subjects
- Humans, Female, Pregnancy, Cesarean Section, Delivery, Obstetric methods, Retrospective Studies, Risk Factors, Lacerations epidemiology, Crohn Disease complications, Crohn Disease epidemiology, Crohn Disease surgery
- Abstract
Objective: Patients with Crohn's disease (CD) may have perineal lesions or a history of anorectal surgery that raise concerns about complications during delivery resulting in a discussion of cesarean section. Our objective was to study the impact of CD on the mode of delivery., Method: We conducted a retrospective study between 2005 and 2019 of the pregnancy outcomes of patients with CD. The primary endpoint was the performance of a cesarean section for a reason related to CD., Results: Among 76 consecutive pregnancies, 19 patients underwent CD-related cesarean section (25%). The main element associated with scheduling a cesarean section was the existence of perineal involvement in 94.7% of cases, compared to 12.3% in the rest of the CD population (p<0.05). The perineal lesions most often involved were fistulas (47.4% versus 1.7%; p = 0.042). There was a history of perineal surgery in 78.9% of cases in the cesarean group vs 10,5% (p < 0.05) and a history of obstetric anal sphincter injury (OASI) in 10.5% of cases vs. 0 (p = 0.047). In women who gave birth vaginally, there were 17.9% episiotomy and one case of OASI (2.6%)., Conclusion: The factors that influenced the choice of delivery route were perineal damage, history of perineal surgery and history of OASI., (Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
18. [SARS-Cov-2 vaccine's acceptance among pregnant women-A cross-sectional survey].
- Author
-
Huré M, Peyronnet V, Sibiude J, Cazenave MG, Anselem O, Luton D, Vauloup-Fellous C, Deruelle P, Cordier AG, Benachi A, Mandelbrot L, Couffignal C, Pauphilet V, Vivanti AJ, and Picone O
- Subjects
- Pregnancy, Infant, Newborn, Humans, Female, COVID-19 Vaccines, Cross-Sectional Studies, SARS-CoV-2, Pregnant Women, COVID-19 prevention & control
- Abstract
Objective: SARS-CoV-2 is more likely to cause severe cases in pregnant women. They were part of the priority groups since April 2021 to benefit from SARS-CoV-2 vaccination before its extent to general population. This contribution aims to evaluate, in the postpartum period, the achievement of COVID-19 vaccination and factors associated in women during their pregnancy., Material and Method: Multicenter cross-sectional survey study conducted from September to December 2021 with online self-questionnaire. All postpartum patients hospitalized in one of the 6 participating maternity hospitals were invited to answer. The questionnaire asked patients about their demographic characteristics, vaccination modalities, vaccine tolerance, and their general perception of vaccination., Results: Of the 371 women who responded, the vaccination rate was 65.7% (IC95% [60.8-70.4]), whom 98.8% entirely during pregnancy. Associated factors with vaccination during pregnancy were older age, higher socio-professional category, and prior information provided by health professionals. Factors that appear to motivate vaccination were personal protection and protection of the newborn. Finally, main factors negatively influencing the vaccination process were the fear of vaccine side effects and the negative perception of vaccines in general., Discussion: Acceptability and information about the vaccine by health professionals is in constant improvement. Information campaigns should be continued to improve the acceptability of vaccination, in light of the accumulating data., (Copyright © 2022 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
19. Diagnostic value of fetal autopsy after early termination of pregnancy for fetal anomalies.
- Author
-
Peyronnet V, Anselem O, Loeuillet L, Roux N, and Tsatsaris V
- Subjects
- Female, Pregnancy, Humans, Autopsy, Retrospective Studies, Pregnancy Trimester, Second, Fetus diagnostic imaging, Fetus abnormalities, Abortion, Induced methods
- Abstract
Background: In early terminations of pregnancy for fetal anomaly (TOPFA) without identified cytogenetic abnormality, a fetal autopsy is recommended for diagnostic purposes, to guide genetic counseling. Medical induction, which allows analysis of a complete fetus, is generally preferred over surgical vacuum aspiration. Our objective was to assess the diagnostic value of fetal autopsies in these early terminations, relative to the first-trimester ultrasound, overall and by termination method., Materials: For this retrospective study at the Port Royal Maternity Hospital, we identified all TOPFA performed from 11 weeks to 16 weeks diagnosed at the first-trimester ultrasound in cases with a normal karyotype. The principal endpoint was the additional value of the autopsy over /compared to the ultrasound and its impact on genetic counseling, globally and by termination method. The secondary objective was to compare the complication rate by method of termination., Results: The study included 79 women during period of 2013-2017: 42 with terminations by medical induction and 37 by aspiration. Fetal autopsy found additional abnormalities in 54.4% of cases, more frequently after medical induction (77.5%) than after aspiration (21.4%, p < .01). Genetic counseling was modified in 20.6% of cases, more often after induction (32.5% vs 3.6%, p < .01). The length of stay was significantly longer and a secondary aspiration was required in 16,7% of case in the medical induction group (p < .01)., Conclusion: Medically induced vaginal expulsion appears preferable and can change genetic counseling for subsequent pregnancies., Competing Interests: NO authors have competing interests.
- Published
- 2022
- Full Text
- View/download PDF
20. Risk factors of relaparotomy for intra-abdominal hemorrhage after cesarean delivery.
- Author
-
Pencole L, Peyronnet V, Mandelbrot L, and Lepercq J
- Subjects
- Case-Control Studies, Cesarean Section adverse effects, Female, Humans, Laparotomy adverse effects, Male, Pregnancy, Risk Factors, Postpartum Hemorrhage etiology, Postpartum Hemorrhage surgery
- Abstract
Objective: the main objective was to identify risk factors of relaparotomy for intra-abdominal hemorrhage (IAH) after cesarean delivery. The secondary objectives were to identify clinical warning signs associated with IAH: heart rate>120/min, systolic blood pressure<90 mmHg, scar bleeding, unconsciousness or abdominal pain with visual analog pain scale > 7 or use of category 3 analgesic medications, in the post-anesthesia care unit and in the post-partum unit., Study Design: a case-control study (1:2 ratio), in two academic tertiary perinatal centers during 2008-2017. Postpartum laparotomies performed for another indication were excluded. The cases were women who underwent relaparotomy for IAH. A control group comprised women who had an uncomplicated cesarean delivery before and after each case., Results: 19,007 women had a cesarean delivery during the study period and among them 52 relaparotomies (0.27 %) for IAH were performed. 48 cases were compared to 96 controls. In multivariate analysis, the existence of a preeclampsia (aOR = 2.8, 95 % IC 1.1-7.4), urgent cesarean (aOR = 3.2, 95 % IC 1.1-9.6), surgical difficulties during initial cesarean (aOR = 9.0, 95 % IC 2.8-23.8), and estimated blood loss > 500 mL during initial cesarean (aOR = 7.4, 95 % IC 2.4-22.5) were independently associated with IAH. Tachycardia > 120/min was the most discriminating factor associated with the occurrence of relaparotomy for IAH (84 %). In the absence of tachycardia, hypotension < 90 mmHg was the second most discriminant factor for IAH (73 %)., Conclusion: preeclampsia, urgent cesarean, surgical difficulties and blood loss > 500 mL during initial cesarean were independently associated with an increased risk of relaparotomy for IAH. Tachycardia and/or hypotension were discriminant-warning signs for severe IAH., Competing Interests: Declaration of Competing Interest The authors report no declarations of interest., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. [N on-pharmacological management of smoking cessation during pregnancy- CNGOF-SFT Expert Report and Guidelines for Smoking Management during Pregnancy].
- Author
-
Peyronnet V, Koch A, Rault E, Perdriolle-Galet E, and Bertholdt C
- Subjects
- Counseling, Female, Humans, Infant, Low Birth Weight, Infant, Newborn, Pregnancy, Smoking, Smoking Prevention, Smoking Cessation
- Abstract
Objectives: To assess the benefit of non-pharmacological intervention promoting on smoking cessation, obstetric and neonatal outcomes, to offer pregnant women who smoke (PWS) optimal care., Methods: We searched Medline Database, Cochrane Library and consulted international guidelines., Results: "Counselling" involving globally all kind of non-pharmacological interventions has a benefit on smoking cessation (NP1) and a moderate benefit on birth weight and prematurity (NP2). The brief intervention seems ineffective on smoking cessation (NP2). The effects of motivational interviewing have not been demonstrated during pregnancy (NP2). Cognitive-behavioral interventions do not show superiority (NP2). Financial incentives have a benefit for smoking cessation and possibly for neonatal outcomes (NP1). Feedback interventions (Co tester) provide heterogeneous results (NP2). Self-help interventions (NP2) and health education (NP2) seem effective on smoking cessation. Hypnotherapy and acupuncture have been little or not studied in PWS. Moderate physical activity did not show a significant effect (NP2) on smoking cessation but seem to reduce craving for tobacco (NP3)., Conclusions: We recommend asking all PWS about their smoking consumption and detailing their smoking history, offering them different types of counselling according to their preferences and involving them multidisciplinary (grade A). The systematic use of feedback is not recommended (grade C) but experience suggests that the CO tester is important in establishing a therapeutic alliance (professional consensus). The use of self-help interventions (grade C) and health education (grade B) are recommended., (Copyright © 2020 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
22. [Management of Resumption Risk in Postpartum for Women who Quit Smoking During Pregnancy - CNGOF-SFT Expert Report and Guidelines for Smoking Management During Pregnancy].
- Author
-
Perdriolle-Galet E, Peyronnet V, and Bertholdt C
- Subjects
- Breast Feeding, Female, Humans, Postpartum Period, Pregnancy, Smoking adverse effects, Smoking Prevention, Smoking Cessation
- Abstract
According to the 2016 National Perinatal Survey, 30.0 % of women smoked before pregnancy, 45.8 % quit smoking in the 1st or 2nd trimester. Many do this only for pregnancy and the risk of postpartum relapse is high (up to 82 % at 1 year). The main factors associated with postpartum abstinence are breastfeeding, not having a smoker at home, and having no symptoms of postpartum depression. No drug treatment can be recommended to prevent the smoking postpartum relapse. Only global counseling can prevent this risk., (Copyright © 2020 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
23. [CNGOF-SFT Expert Report and Guidelines for Smoking Management during Pregnancy-Short Text].
- Author
-
Grangé G, Berlin I, Bretelle F, Bertholdt C, Berveiller P, Blanc J, DiGuisto C, Dochez V, Garabedian C, Guerby P, Koch A, Le Lous M, Perdriolle-Galet E, Peyronnet V, Rault E, Torchin H, and Legendre G
- Subjects
- Child, Female, Humans, Nicotine, Pregnancy, Smoking, Smoking Prevention, Tobacco Use Cessation Devices, Electronic Nicotine Delivery Systems, Smoking Cessation
- Abstract
Objectives: To provide up-to-date evidence-based guidelines for the management of smoking cessation during pregnancy., Methods: Systematic review of the international literature. We identified papers published between January 2003 and April 2019 in Cochrane PubMed, and Embase databases with predefined keywords. All reports published in French and English relevant to the areas of focus were included and classified according the level of evidence ranging from 1 (highest) to 4 (lowest). The strength of the recommendations was classified according to the Haute Autorité de santé, France (ranging from A, highest to C, lowest)., Results: "Counseling", involving globally all kind of non-pharmacological interventions, has a modest benefit on smoking cessation, birth weight and prematurity. Moderate physical activity did not show a significant effect on smoking cessation. The systematic use of feedback by measuring the expired air carbon monoxide concentration do not influence smoking abstinence but it may be used in establishing a therapeutic alliance. The use of self-help interventions and health education are recommended in helping pregnant smokers quit. The prescription of nicotine replacement therapies (NRT) may be offered to any pregnant woman who has failed stopping smoking without medication This prescription can be initiated by the health care professional taking care of the pregnant woman in early pregnancy. There is no scientific evidence to propose the electronic cigarette for smoking cessation to pregnant smokers; it is recommended to provide the same advice and to use methods that have already been evaluated. The use of waterpipe (shisha/narghile) during pregnancy is associated with decreased fetal growth. It is recommended not to use waterpipe during pregnancy. Breastfeeding is possible in smokers, but less often initiated by them. Although its benefit for the child's development is not demonstrated to date, breastfeeding allows the mother to reduce or stop smoking. The risk of postpartum relapse is high (up to 82% at 1 year). The main factors associated with postpartum abstinence are breastfeeding, not having a smoker at home, and having no symptoms of postpartum depression., Conclusions: Smoking during pregnancy concerns more than hundred thousand women and their children per year in France. It is a major public health burden. Health care professionals should be mobilized for reducing or even eradicating it., (Copyright © 2020 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
24. [SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF].
- Author
-
Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet JC, Mandelbrot L, Nisand I, Vayssière C, Yazpandanah Y, Luton D, and Picone O
- Subjects
- COVID-19, Coronavirus Infections diagnosis, Coronavirus Infections transmission, Female, Guidelines as Topic, Humans, Infant, Newborn, Pandemics, Pneumonia, Viral diagnosis, Pneumonia, Viral transmission, Pregnancy, Pregnancy Complications, Infectious prevention & control, SARS-CoV-2, Societies, Medical, Betacoronavirus, Coronavirus Infections therapy, Infectious Disease Transmission, Vertical prevention & control, Obstetrics standards, Pneumonia, Viral therapy, Pregnancy Complications, Infectious diagnosis
- Abstract
A new coronavirus (SARS-CoV-2) highlighted at the end of 2019 in China is spreading across all continents. Most often at the origin of a mild infectious syndrome, associating mild symptoms (fever, cough, myalgia, headache and possible digestive disorders) to different degrees, SARS-Covid-2 can cause serious pulmonary pathologies and sometimes death. Data on the consequences during pregnancy are limited. The first Chinese data published seem to show that the symptoms in pregnant women are the same as those of the general population. There are no cases of intrauterine maternal-fetal transmission, but cases of newborns infected early suggest that there could be vertical perpartum or neonatal transmission. Induced prematurity and cases of respiratory distress in newborns of infected mothers have been described. Pregnancy is known as a period at higher risk for the consequences of respiratory infections, as for influenza, so it seems important to screen for Covid-19 in the presence of symptoms and to monitor closely pregnant women. In this context of the SARS-Covid-2 epidemic, the societies of gynecology-obstetrics, infectious diseases and neonatalogy have proposed a French protocol for the management of possible and proven cases of SARS-Covid-2 in pregnant women. These proposals may evolve on a daily basis with the advancement of the epidemic and knowledge in pregnant women. Subsequently, an in-depth analysis of cases in pregnant women will be necessary in order to improve knowledge on the subject., (Copyright © 2020 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. Does Changing Antiretroviral Therapy in the First Trimester of Pregnancy for Safety Concerns Have an Impact on Viral Suppression?
- Author
-
Peyronnet V, Warszawski J, Sibiude J, Dialla O, Bourgeois-Moine A, Bui E, Toulza CS, Peretti D, Brunet-Cartier C, Avettand-Fenoel V, Chenadec JL, Faye A, Tubiana R, and Mandelbrot L
- Subjects
- Adult, Anti-HIV Agents adverse effects, Drug Substitution adverse effects, Female, HIV Infections drug therapy, Humans, Infectious Disease Transmission, Vertical prevention & control, Logistic Models, Pregnancy, Pregnancy Outcome, Pregnancy Trimester, First, Propensity Score, Prospective Studies, Survival Analysis, Viral Load drug effects, Young Adult, Anti-HIV Agents therapeutic use, HIV Infections complications, HIV-1 drug effects, Pregnancy Complications, Infectious drug therapy
- Abstract
Objective: To determine whether changing antiretroviral therapy (ART) during pregnancy because of concern about fetal risks led to poorer virological outcomes., Methods: All pregnancies in women with HIV-1 infection enrolled in the national multicenter prospective French Perinatal cohort at 14 week gestation or more were included between January 2005 and December 2015, if the mother was on ART at conception with a plasma viral load <50 copies/mL. The reasons for a change in the ART were analyzed according to treatment guidelines at the time of the pregnancy and defined as for safety concerns in the absence of reported maternal intolerance. Virological and pregnancy outcomes were studied by survival analysis and logistic regression adjusted for a propensity score established for each patient according to baseline characteristics., Results: Of 7079 pregnancies in the overall cohort, 1797 had ART at conception with a viral load <50 copies/mL before 14 week gestation. Of these, 22 changed regimens in the first trimester for intolerance, and 411 of the remaining 1775 (23%) solely for safety concerns. The proportion of change was higher when the initial treatment was not recommended in the national guidelines (OR adjusted: 23.1 [14.0-38.2]), than when it was an alternative option (ORa: 2.2 [1.3-3.7]), as compared to recommended first-line regimens. Treatment changes for safety concerns did not lead to poorer virological control, compared with pregnancies without such changes (19.3% vs. 15.6%, HRa: 1.0 [0.7-1.4])., Conclusions: Changing ART early in pregnancy to regimens considered safer for pregnancy, and neonatal health did not have a destabilizing effect on viral suppression.
- Published
- 2019
- Full Text
- View/download PDF
26. Impact of recommended changes in labor management for prevention of the primary cesarean delivery.
- Author
-
Thuillier C, Roy S, Peyronnet V, Quibel T, Nlandu A, and Rozenberg P
- Subjects
- Adult, Clinical Protocols, Female, Humans, Interrupted Time Series Analysis, Labor Stage, First, Labor Stage, Second, Labor, Induced, Parity, Practice Guidelines as Topic, Pregnancy, Retrospective Studies, Cesarean Section statistics & numerical data, Labor, Obstetric, Obstetric Labor Complications diagnosis, Obstetric Labor Complications surgery
- Abstract
Background: The dramatic rise in cesarean delivery rates worldwide in recent decades, without evidence of a concomitant decrease in cerebral palsy rates, has raised concerns about its potential negative consequences for maternal and infant health. In 2014, the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine jointly published an Obstetric Care Consensus for safe prevention of the primary cesarean delivery., Objective: We sought to assess whether modification of our protocol to implement these recommendations helped to decrease our primary cesarean delivery rate safely., Study Design: This is a before-and-after retrospective cohort study at a university referral hospital. In March 2014, the threshold for defining active labor changed from 4 to >6 cm and arrest of first-stage labor from lack of cervical change despite regular contractions after 3 hours of oxytocin administration with amniotomy and epidural anesthesia to no change after 4 hours of adequate or 6 hours of inadequate contractions in women with an epidural. The definition of second-stage arrest of labor changed simultaneously from lack of progress for 3 hours with adequate contractions in women with epidural anesthesia to no progress for ≥4 hours in nulliparas or 3 hours in multiparas with an epidural. We compared maternal and neonatal outcomes over two 1 year periods: from March 2013 to February 2014 (before, preguideline) and from June 2014 to May 2015 (after, postguideline). We included all women with singleton pregnancies at ≥37 weeks' gestation, in vertex presentation, in spontaneous or induced labor, and with epidural anesthesia. We excluded women with an elective or previous cesarean delivery and those with obstetric or fetal complications., Results: This study included 3283 and 3068 women in the before and after periods, respectively. The groups had similar general and obstetric characteristics. The global cesarean delivery rate decreased significantly from 9.4% in the preguideline to 6.9% in the postguideline period (odds ratio, 0.71; 95% confidence interval, 0.59-0.85; P < .01). The cesarean delivery rate for arrest of first-stage labor fell by half, from 1.8% to 0.9% (odds ratio, 0.51; 95% confidence interval, 0.31-0.81; P < .01) but was significant only among nulliparous women. The cesarean delivery rate for second-stage arrest of labor decreased but not significantly between periods (1.3% vs 1.0%; odds ratio, 0.73; 95% confidence interval, 0.44-1.22; P = .2), and the cesarean delivery rate for failure of induction remained similar (3.7% vs 3.5%; odds ratio, 1.06; 95% confidence interval, 0.06-13.24; P = .88). The median duration of labor before cesarean delivery also became significantly longer among nulliparous women during the later period. Maternal and neonatal outcomes did not differ between the 2 periods, except that the rate of 1 minute Apgar score <7 fell significantly in the later period (8.4% vs 6.9%; odds ratio, 0.80; 95% confidence interval, 0.66-0.97; P = .02)., Conclusion: The modification of our protocol by implementing the new consensus recommendations was associated with a reduction of the rate of primary cesarean delivery performed for arrest of labor with no apparent increase in immediate adverse neonatal outcomes in nulliparous women at term with singleton pregnancies in vertex presentation and with epidural anesthesia. Further studies are needed to assess the long-term maternal and neonatal safety of these policies., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
27. [Impact of the detection of small for gestational age fetuses on the neonatal prognosis].
- Author
-
Peyronnet V, Sibiude J, Mandelbrot L, and Kayem G
- Subjects
- Birth Weight, Cesarean Section statistics & numerical data, Cohort Studies, Female, Fetal Weight, Gestational Age, Humans, Infant, Newborn, Pregnancy, Premature Birth epidemiology, Prognosis, Retrospective Studies, Ultrasonography, Prenatal, Infant, Small for Gestational Age, Prenatal Diagnosis
- Abstract
Objective: We sought to evaluate whether the antenatal identification of small for gestational age (SGA) fetuses could influence the neonatal and obstetric prognosis., Methods: This was a retrospective cohort study. All liveborn singleton neonates with a birthweight<3rd centile, born>32 weeks of gestation between January 1, 2011 and December 31, 2012 were included. Fetuses were considered "suspected SGA" when the estimated fetal weight was<10th centile or when a diagnosis of clinical or ultrasound SGA was explicitly noted in the record. Obstetrical and neonatal follow-up and outcomes of suspected SGA (SGAS group) and non-suspected (SGANS group) were compared, with Chi
2 and the Fisher exact test when appropriate., Results: Hundred and forty-seven neonates were included. Among these, 54% were suspected SGA before birth. Gestational age was lower (38.5 weeks gestation [WG] vs. 39.6 WG, P<0.001) and there was a higher preterm birth rate in the SGAS group (10% vs. 0%, P=0.005). The rate of elective cesarean sections (17% vs. 3%, P=0.005) was higher in the SGAS group, whereas the rate of nonelective cesarean sections was lower (20% vs. 33%, P=0.002). Neonatal morbidity was similar in both groups, as well as birth weight., Conclusion: SGA fetal screening in our cohort was associated with a higher rate of medical intervention and preterm birth without neonatal benefit. Nevertheless, the study's power and methodology are not adequate to reduce the risk of fetal death in utero or severe asphyxia associated with non-identification of a SGA fetus., (Copyright © 2017 Elsevier Masson SAS. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
28. Lower limbs venous compression reduces the incidence of maternal hypotension following epidural analgesia during term labor.
- Author
-
Peyronnet V, Roses A, Girault A, Bonnet MP, Goffinet F, Tsatsaris V, and Lecarpentier E
- Subjects
- Adult, Female, Humans, Pregnancy, Analgesia, Epidural adverse effects, Hypotension etiology, Hypotension prevention & control, Stockings, Compression statistics & numerical data
- Abstract
Objective(s): Every year in France, 10% to 20% of the 600 000 women given epidural analgesia during labor experience hypotension, which in 15% of cases is associated with fetal heart rate abnormalities. The efficiency of lower limbs venous compression in preventing the occurrence of maternal hypotension after neuraxial anesthesia has already been demonstrated, but only in the context of scheduled cesarean section. We assessed the preventive effect of medical lower limbs venous compression on the incidence of maternal hypotension after epidural analgesia during spontaneous term labor., Study Design: This before/after, single-center study in a university hospital included 93 women in spontaneous labor at term who between 1 January and 31 March 2015 with epidural analgesia plus lower limbs compression and 202 women in spontaneous labor at term who delivered between 1 and 31 December 2014 with epidural analgesia without lower limbs compression (control group). The main outcome was maternal hypotension (systolic blood pressure <90mmHg and/or delta >20%) in the 15min after epidural analgesia., Results: In the lower limbs compression group the incidence of hypotension 15min after epidural analgesia was significantly lower than in the control group (3.23% versus 23.3%, adjusted odds ratio=0.1 [0.03; 0.35]). The incidence of fetal heart rate abnormalities was unsignificantly lower in the lower limbs compression group than in the control group (10.7% versus 16.34%, p=0.22)., Conclusion: The results suggest that medical lower limbs compression (20-36mmHg) in women in spontaneous labor at term, could significantly reduce the incidence of maternal hypotension following epidural analgesia. A prospective, randomized, open trial would allow confirmation of these preliminary results., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
29. [Detection of small for gestational age fetuses during third trimester ultrasound. A monocentric observational study].
- Author
-
Peyronnet V, Kayem G, Mandelbrot L, and Sibiude J
- Subjects
- Biometry methods, Female, Humans, Pregnancy, Pregnancy Trimester, Third, Retrospective Studies, Fetal Weight, Gestational Age, Infant, Small for Gestational Age, Ultrasonography, Prenatal
- Abstract
Objectives: Fetus small for gestational age (SGA) screening rate is evaluated around 21,7 % in France. Recommendations were developed to improve the efficiency of ultrasound conducted in the third trimester (T3), because neonatal consequences can be significant. This study aims to evaluate screening of SGA during T3 ultrasound and to describe causes for failure and differences with the recommendations of CNGOF., Methods: All children born between 2011 and 2012 with a birth weight below the 3rd percentile were included in this observational, retrospective, monocentric study. We noted that the diagnosis of SGA was placed on file. Then, as recommended by the CNGOF, we calculated estimated fetal weight (EFW) with Hadlock 3 and Hadlock 4, and the corresponding percentiles, using the biometrics from the ultrasound report. We thus could evaluate a new screening rate with SGA fetus identified through this technique., Results: A total of 142 patients were included. By calculating correctly all EFW and checking abdominal circumference percentiles, the screening rate of SGA fetuses with T3 ultrasound increased from 40 % to 50 % and the overall screening rate (clinical and ultrasound) from 54 % to 66 %., Conclusion: By following the recommendations we found a real improvement in fetal SGA screening rates to T3 ultrasound with a potential benefit for their care., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.